Who Owns Gyre Therapeutics Stock?
NASDAQ: GYREHealthcareBiotechnologyUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 8.24%
- Held by insiders
- 74.40%
- Institutional holders
- 87
- Institutions 8.2%
- Insiders 74.4%
- Public and other 17.4%
Who owns Gyre Therapeutics stock?
Institutional investors own about 8.2% of Gyre Therapeutics's shares, spread across 87 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 74.40% of GYRE.
The largest institutional holders are HSG Holding Ltd (3.36%), Blackrock Inc. (0.89%) and Octagon Capital Advisors LP (0.86%). Together, the top 10 institutions control 7.2% of shares outstanding. In their latest filings, 8 of the top 10 institutions increased their GYRE positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of GYRE
| Institution | Shares | % Held | Change |
|---|---|---|---|
| HSG Holding Ltd | 3.75M | 3.36% | +100.0% |
| Blackrock Inc. | 993.94K | 0.89% | +31.0% |
| Octagon Capital Advisors LP | 954.42K | 0.86% | +100.0% |
| Vanguard Capital Management LLC | 876.93K | 0.79% | -10.9% |
| Geode Capital Management, LLC | 532.95K | 0.48% | +23.5% |
| State Street Corporation | 245.40K | 0.22% | +13.4% |
| Charles Schwab Investment Management, Inc. | 184.29K | 0.17% | +11.5% |
| Northern Trust Corporation | 169.54K | 0.15% | +26.7% |
| SBI Securities Co., Ltd. | 166.75K | 0.15% | -2.4% |
| Vanguard Fiduciary Trust Co | 151.07K | 0.14% | +9.7% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of GYRE
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 614.65K | 0.55% |
| iShares Trust-iShares Russell 2000 ETF | 388.44K | 0.35% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 238.69K | 0.21% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 199.91K | 0.18% |
| iShares Trust-iShares Russell 2000 Growth ETF | 121.65K | 0.11% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 110.87K | 0.10% |
| SCHWAB STRATEGIC TRUST-Schwab U.S. Small-Cap ETF | 99.89K | 0.09% |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 62.21K | 0.06% |
| VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund | 60.10K | 0.05% |
| SCHWAB CAPITAL TRUST-Schwab Small-Cap Index Fund | 44.88K | 0.04% |
Frequently asked questions
Who is the largest shareholder of Gyre Therapeutics?
HSG Holding Ltd is the largest institutional shareholder of GYRE, owning 3.36% of shares outstanding (3.75M shares) as of its latest 13F filing.
What percentage of Gyre Therapeutics is owned by institutions?
Institutions own about 8.2% of GYRE shares and 32.2% of the public float.
How much of Gyre Therapeutics do insiders own?
Insiders, such as officers and directors, own about 74.40% of GYRE shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.